Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1050 of 1631 entries
View as:

Comparative Cycle Control Europe

Phase: N/A Priority: Normal
NCT ID: NCT00185367 Org: User:
Start: 03/31/05 End: 09/30/06 Due: 09/30/07

A Pharmacodynamic Study Comparing Zegerid® and Prilosec OTC® (Study CL2008-02)(P07814)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00765206 Org: User:
Start: 05/31/08 End: 08/31/08 Due: 08/31/09

Yasmin Post Marketing Surveillance

Phase: N/A Priority: Normal
NCT ID: NCT00923572 Org: User:
Start: 12/31/07 End: 08/31/13 Due: 08/31/14

Study for Evaluation of Efficacy and Safety of SH L 749 to Indolent B-cell Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00220285 Org: User:
Start: 08/31/04 End: 10/31/05 Due: 10/31/06

Refametinib(BAY86-9766) in RAS Mutant Hepatocellular Carcinoma (HCC)

Phase: N/A Priority: Normal
NCT ID: NCT01915589 Org: User:
Start: 09/16/13 End: 10/08/14 Due: 10/08/15

A Study to Learn More About How Radium-223 is Being Used With Other Treatments in European Patients Who Have Not Received Radium-223 Before

Phase: N/A Priority: Normal
NCT ID: NCT04587427 Org: User:
Start: 05/15/21 End: 05/30/23 Due: 05/30/24

Human Phototoxicity Test

Phase: N/A Priority: Normal
NCT ID: NCT02751489 Org: User:
Start: 05/31/16 End: 05/31/16 Due: 05/31/17

A Trial to Learn How Well Finerenone Works and How Safe it is in Adult Participants With Non-diabetic Chronic Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT05047263 Org: User:
Start: 09/21/21 End: 02/09/26 Due: 02/09/27

EYLEA Age-Related Macular Degeneration (AMD) Post-marketing Surveillance in Japan

Phase: N/A Priority: Normal
NCT ID: NCT01756248 Org: User:
Start: 12/26/12 End: 05/20/19 Due: 05/20/20

Relative Bioavailability of Sorafenib Tablet for Oral Suspension

Phase: N/A Priority: Normal
NCT ID: NCT02538393 Org: User:
Start: 11/20/15 End: 06/15/16 Due: 06/15/17

QOLBET Quality Of Life in Patients With Early Relapsing-remitting Multiple Sclerosis Treated With BETaferon® in Korea

Phase: N/A Priority: Normal
NCT ID: NCT01071694 Org: User:
Start: 01/31/11 End: 12/31/12 Due: 12/31/13

Assessment of Compliance With Antihypertensive Telmisartan Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00470886 Org: User:
Start: 04/30/07 End: 01/31/10 Due: 01/31/11

Darolutamide in Addition to ADT Versus ADT in Metastatic Hormone-sensitive Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04736199 Org: User:
Start: 02/23/21 End: 01/30/26 Due: 01/30/27

Safety and Efficacy of BAY94-9027 in Previously Treated Male Children With Haemophilia A

Phase: N/A Priority: Normal
NCT ID: NCT01775618 Org: User:
Start: 05/29/13 End: 02/19/20 Due: 02/19/21

Study to Characterize Lung Deposition, Pharmacokinetics, Safety and Tolerability of Single Inhalations of Radiolabeled Ciprofloxacin Dry Powder in Healthy Subjects and Patients With Chronic Lung Diseases

Phase: N/A Priority: Normal
NCT ID: NCT01538667 Org: User:
Start: 04/30/12 End: 07/31/12 Due: 07/31/13

Study to Investigate Safety, Absorption, Elimination, and Drug Effect of BAY2327949 in Participants With Different Renal Function Status

Phase: N/A Priority: Normal
NCT ID: NCT04004195 Org: User:
Start: 07/10/19 End: 06/04/20 Due: 06/04/21

Mirena in Idiopathic Menorrhagia

Phase: N/A Priority: Normal
NCT ID: NCT00868153 Org: User:
Start: 08/31/04 End: 11/30/08 Due: 11/30/09

Study to Determine Skin Irritation and/or Sensitization Potential of an Antifungal Cream Containing Trolamine (Repeated Insult Patch Test)

Phase: N/A Priority: Normal
NCT ID: NCT04531540 Org: User:
Start: 09/09/13 End: 10/18/13 Due: 10/18/14

18475 - Sun Protection Factor Assay

Phase: N/A Priority: Normal
NCT ID: NCT02774252 Org: User:
Start: 08/13/15 End: 09/03/15 Due: 09/03/16

Evaluating of the Efficacy and Safety of Vardenafil in Subjects With Erectile Dysfunction

Phase: N/A Priority: Normal
NCT ID: NCT00662441 Org: User:
Start: 09/30/03 End: 06/30/04 Due: 06/30/05

Clinical Study to Evaluate the Treatment Effect and Safety of BAY1817080 in Patients With Overactive Bladder (OAB)

Phase: N/A Priority: Normal
NCT ID: NCT04545580 Org: User:
Start: 09/16/20 End: 01/21/22 Due: 01/21/23

Sun Protection Factor Assay

Phase: N/A Priority: Normal
NCT ID: NCT02803008 Org: User:
Start: 10/29/15 End: 11/05/15 Due: 11/05/16

A Study of Molidustat for Correction of Renal Anemia in Non-dialysis Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03350321 Org: User:
Start: 12/12/17 End: 10/11/19 Due: 10/11/20

Copanlisib Pharmacodynamic Study

Phase: N/A Priority: Normal
NCT ID: NCT02155582 Org: User:
Start: 08/12/14 End: 03/16/17 Due: 03/16/18

FDA Phase IV - Commitment - Retinal Function Study

Phase: N/A Priority: Normal
NCT ID: NCT00461565 Org: User:
Start: 02/28/05 End: 10/31/06 Due: 10/31/07